IBB icon

iShares Biotechnology ETF

428 hedge funds and large institutions have $3.72B invested in iShares Biotechnology ETF in 2016 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 149 increasing their positions, 122 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
428
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
20
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$629M
Puts
$1.39B
Net Calls
Net Calls Change

Top Buyers

1 +$130M
2 +$127M
3 +$79.5M
4
Citadel Advisors
Citadel Advisors
Florida
+$50.6M
5
SG Americas Securities
SG Americas Securities
New York
+$45.3M

Top Sellers

1 -$157M
2 -$142M
3 -$128M
4
LPL Financial
LPL Financial
California
-$71M
5
Jane Street
Jane Street
New York
-$69.1M
Name Holding Trade Value Shares
Change
Change in
Stake
301
$288K
302
$287K
303
$286K
304
$283K
305
$277K
306
$266K
307
$266K
308
$261K
309
$261K
310
$260K
311
$257K
312
$256K
313
$255K
314
$250K
315
$250K
316
$248K
317
$246K
318
$242K
319
$239K
320
$238K
321
$237K
322
$236K
323
$235K
324
$233K
325
$231K